TRENARY C RUSSELL III 4
4 · Outlook Therapeutics, Inc. · Filed Mar 22, 2024
Insider Transaction Report
Form 4
TRENARY C RUSSELL III
DirectorCEO and President
Transactions
- Award
Stock Option (Right to Buy)
2024-03-20+455,000→ 455,000 totalExercise: $6.78Exp: 2034-03-20→ Common Stock (455,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on March 20, 2025, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.